Durante la pandemia, los recursos federales se orientaron a reforzar los presupuestos de los estados para que pudieran responder a la emergencia por covid-19. Sin embargo, ya desde entonces, las autoridades de salud pública advirtieron que se avecinaba un inminente ciclo de auge y debacle en el financiamiento. Anticiparon que la crisis se presentaría cuando…
RAPID CITY, S.D. — Native American tribes and health organizations are responding to concerns about low measles vaccination rates and patients’ difficulty getting care as an outbreak of the disease spreads around the country. They’re hosting mobile vaccine clinics, running social media campaigns, making sure health providers are vaccinated, reaching out to the parents of…
Last week, CMS announced the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model. The program basically is a ‘most favored nation’ style reference pricing based on net prices from developed countries. The program builds on the Medicaid Drug Rebate Program (MDRP). Specific details specified on the CMS website include: Participating manufacturers whose applications are accepted…
As Congress weighs potential cuts in federal Medicaid spending through budget reconciliation, one option under consideration is to limit the use of state taxes on providers. This brief uses data from KFF’s 2024-2025 survey of Medicaid directors to describe states’ current provider taxes and the federal rules governing them.
KFF is tracking the Medicaid provisions in the 2025 federal budget bill, including new Medicaid work and verification requirements and a reduction in the expansion match rate for states that use their own funds to cover undocumented immigrants.
Beginning Feb. 16, noncompliance in protecting confidentiality of SUD patient records could result in penalties aligned with those available under HIPAA
The Peterson Health Technology Institute outlined five key recommendations for employers seeking to design sustainable GLP-1 coverage. The post PHTI: How Employers Can Manage GLP-1 Coverage appeared first on MedCity News.
Rocket Pharmaceuticals received the rare pediatric disease priority review voucher with the accelerated FDA approval for Kresladi in March. The non-dilutive capital from the voucher’s sale will support a pipeline that includes a gene therapy in pivotal clinical testing for the rare genetic disorder Danon disease. The post Rocket Pharma Reaps $180M From Sale of…
[Sponsored] Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences. The post The Hidden Administrative Tasks Draining Small Practices appeared first on MedCity News.
Oshi Health’s $60 million Series C funding round was led by Oak HC/FT and included participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. The post Oshi Health Secures $60M To Scale Virtual Digestive Care appeared first on MedCity News.